Impact of reirradiation, chemotherapy, and immunotherapy on survival of patients with recurrent lung cancer: A single‐center retrospective analysis-Reference-Cited by-同舟云学术

Impact of reirradiation, chemotherapy, and immunotherapy on survival of patients with recurrent lung cancer: A single‐center retrospective analysis

Published:2021-02-14 Issue:8 Volume:12 Page:1162-1170
ISSN:1759-7706
Container-title:Thoracic Cancer
language:en
Short-container-title:Thorac Cancer

Author:

Grambozov Brane¹^ORCID,Wass Romana²³,Stana Markus¹,Gerum Sabine¹,Karner Josef¹,Fastner Gerd¹,Studnicka Michael²,Sedlmayer Felix¹⁴,Zehentmayr Franz¹⁴^ORCID

Affiliation:

1. Department of Radiation Oncology Paracelsus Medical University, SALK Salzburg Austria

2. Department of Pneumology Paracelsus Medical University, SALK Salzburg Austria

3. Department of Pulmonology Kepler University Hospital Linz Austria

4. radART – Institute for Research and Development on Advanced Radiation Technologies Paracelsus Medical University Salzburg Austria

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/1759-7714.13884

Reference34 articles.

1. Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC

2. Durvalumab after Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer

3. Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer

4. First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer

5. Special topics in immunotherapy and radiation therapy: reirradiation and palliation

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pretreatment 18-FDG-PET/CT parameters can serve as prognostic imaging biomarkers in recurrent NSCLC patients treated with reirradiation-chemoimmunotherapy;Radiotherapy and Oncology;2023-08

2. Follow up and surveillance post lung cancer surgery: a narrative review;Video-Assisted Thoracic Surgery;2023-03

3. Potential advantages of gEUD optimisation as compared with conventional physical optimisation for stereotactic treatment planning;Journal of Radiotherapy in Practice;2023

4. The value of completion residual lung resection in ipsilateral recurrent non-small cell lung cancer;Frontiers in Surgery;2022-11-09

5. High Dose Thoracic Re-Irradiation and Chemo-Immunotherapy for Centrally Recurrent NSCLC;Cancers;2022-01-23